2022年7月6日 · Paroxysmal sympathetic hyperactivity (PSH) is a pattern of recurrent bursts of dysregulated sympathetic activity, resulting from severe brain injury. These episodes of …

Currently, the Paroxysmal Sympathetic Hyperactivity-Assessment Measure (PSH-AM) scale consists of two separate constructs: (1) the clinical feature scale (CFS), to identify the intensity …

PSH is defined as a clinical syndrome manifested by paroxysmal episodes of sympathetic activity that occur in patients with severe acute brain injury [5]. Core clinical features include …

Diagnosis of PSH is made using the paroxysmal sympathetic hyperactivity-assessment measure (PSH-AM) score, which comprises “clinical features severity” (CFS) score and “diagnosis …

A consensus set of diagnostic criteria named PSH-Assessment Measure (PSH-AM) has been developed recently, which is consisted of two components: a diagnosis likelihood tool derived …

Paroxysmal sympathetic hyperactivity (PSH) is a syndrome that causes episodes of increased activity of the sympathetic nervous system. Hyperactivity of the sympathetic nervous system …

Currently, the Paroxysmal Sympathetic Hyperactivity-Assessment Measure (PSH-AM) scale consists of two separate constructs: (1) the clinical feature scale (CFS), to identify the intensity …

2020年11月10日 · Diagnosis of PSH is made using the paroxysmal sympathetic hyperactivity-assessment measure (PSH-AM) score, which comprises "clinical features severity" (CFS) …

Returns a data.frame with percentage of cens, cause 1, Test Statistic, d.f. ,p-value. The proposed score test employs Schoenfeld residuals adapted to competing risks data.

2018年3月8日 · Identifying factors that risk-stratify patients with primary brain injury for PSH is important for early and appropriate diagnosis and treatment. PSH has a varying incidence of …